Joka et al. [47] reported that both total serum CK18 and CK18 fragments could accurately differentiate healthy controls or simple steatosis from NASH and discriminate patients with different fibrosis stages from healthy controls. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.